These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21814047)

  • 1. Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy.
    Buckley CL; Stokes AJ
    Channels (Austin); 2011; 5(4):367-74. PubMed ID: 21814047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".
    Horton JS; Shiraishi T; Alfulaij N; Small-Howard AL; Turner HC; Kurokawa T; Mori Y; Stokes AJ
    Channels (Austin); 2019 Dec; 13(1):1-16. PubMed ID: 30424709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic ablation of TRPV1 exacerbates pressure overload-induced cardiac hypertrophy.
    Zhong B; Rubinstein J; Ma S; Wang DH
    Biomed Pharmacother; 2018 Mar; 99():261-270. PubMed ID: 29334670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased transient receptor potential vanilloid type 1 (TRPV1) channel expression in hypertrophic heart.
    Thilo F; Liu Y; Schulz N; Gergs U; Neumann J; Loddenkemper C; Gollasch M; Tepel M
    Biochem Biophys Res Commun; 2010 Oct; 401(1):98-103. PubMed ID: 20833132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.
    Horton JS; Buckley CL; Stokes AJ
    Channels (Austin); 2013 Jan; 7(1):17-22. PubMed ID: 23221478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary capsaicin ameliorates pressure overload-induced cardiac hypertrophy and fibrosis through the transient receptor potential vanilloid type 1.
    Wang Q; Ma S; Li D; Zhang Y; Tang B; Qiu C; Yang Y; Yang D
    Am J Hypertens; 2014 Dec; 27(12):1521-9. PubMed ID: 24858305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold stress accentuates pressure overload-induced cardiac hypertrophy and contractile dysfunction: role of TRPV1/AMPK-mediated autophagy.
    Lu S; Xu D
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):8-15. PubMed ID: 24211590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient receptor potential vanilloid 1-expressing cardiac afferent nerves may contribute to cardiac hypertrophy in accompany with an increased expression of brain-derived neurotrophic factor within nucleus tractus solitarius in a pressure overload model.
    Shibata R; Shinohara K; Ikeda S; Iyonaga T; Matsuura T; Kashihara S; Ito K; Kishi T; Hirooka Y; Tsutsui H
    Clin Exp Hypertens; 2022 Apr; 44(3):249-257. PubMed ID: 35060414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysferlin Enables Tubular Membrane Proliferation in Cardiac Hypertrophy.
    Paulke NJ; Fleischhacker C; Wegener JB; Riedemann GC; Cretu C; Mushtaq M; Zaremba N; Möbius W; Zühlke Y; Wedemeyer J; Liebmann L; Gorshkova AA; Kownatzki-Danger D; Wagner E; Kohl T; Wichmann C; Jahn O; Urlaub H; Toischer K; Hasenfuß G; Moser T; Preobraschenski J; Lenz C; Rog-Zielinska EA; Lehnart SE; Brandenburg S
    Circ Res; 2024 Aug; 135(5):554-574. PubMed ID: 39011635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
    Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload.
    Manso AM; Li R; Monkley SJ; Cruz NM; Ong S; Lao DH; Koshman YE; Gu Y; Peterson KL; Chen J; Abel ED; Samarel AM; Critchley DR; Ross RS
    J Biol Chem; 2013 Feb; 288(6):4252-64. PubMed ID: 23266827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
    Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
    Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
    Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
    J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Receptor Potential Vanilloid Type 1 Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes.
    Wang Y; Li X; Xu X; Qu X; Yang Y
    J Cardiovasc Pharmacol; 2022 Sep; 80(3):430-441. PubMed ID: 35881904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling.
    Andenæs K; Lunde IG; Mohammadzadeh N; Dahl CP; Aronsen JM; Strand ME; Palmero S; Sjaastad I; Christensen G; Engebretsen KVT; Tønnessen T
    PLoS One; 2018; 13(7):e0201422. PubMed ID: 30052659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoGEF12 controls cardiac remodeling by integrating G protein- and integrin-dependent signaling cascades.
    Takefuji M; Krüger M; Sivaraj KK; Kaibuchi K; Offermanns S; Wettschureck N
    J Exp Med; 2013 Apr; 210(4):665-73. PubMed ID: 23530122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated development of pressure overload-induced cardiac hypertrophy and dysfunction in an RyR2-R176Q knockin mouse model.
    van Oort RJ; Respress JL; Li N; Reynolds C; De Almeida AC; Skapura DG; De Windt LJ; Wehrens XH
    Hypertension; 2010 Apr; 55(4):932-8. PubMed ID: 20157052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
    Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.